RESUMEN
Introduction: During the COVID-19 pandemic, patients with worse evolution presented clinical deterioration 7-10 days after the onset of symptoms, which suggests that the inflammatory response could participate in the pathophysiology of the disease. The objective of this study was to evaluate the association between plasma C-reactive protein (PCr) on hospital admission and mechanical ventilation requirement during hospitalization in adults with COVID-19. Methods: Retrospective, observational cohort at a private center in the province of Buenos Aires. Hospitalized adults diagnosed with COVID-19 by nasal swab using real time transcription polymerase chain reaction or antigen were included. The primary outcome was the association between high plasma PCr values on hospital admission (≥8 mg/L) and mechanical ventilation requirement during hospitalization. Results: Of the 1,242 patients enrolled, 19.4% required mechanical ventilation and 11.7% died during the hospitalization. The PCr of the patients who required mechanical ventilation was higher than that of those who did not require mechanical ventilation (9.45 [5.20-18.70] mg/L vs 4.95 [1.80-10.70] mg/L; p < 0.01). PCr analyzed as a continuous variable (OR = 1.39; 95%CI 1.21-1.60; p < 0.001) and as a categorical variable (≥8 mg/L) (OR = 2.66; 95%CI 2.19 -3.78, p < 0.001) presented a significant association with the requirement of mechanical ventilation during hospitalization. Additionally, a significant association was found between PCr and in-hospital mortality. Conclusion: Plasma PCr on hospital admission could predict clinical evolution in adult patients hospitalized for COVID-19.
Introducción: Durante la pandemia por COVID-19, los pacientes con peor evolución presentaron deterioro clínico a los 7-10 días del inicio de síntomas, lo cual sugiere que la respuesta inflamatoria podría participar de la fisiopatogenia de la enfermedad. Objetivo: El objetivo de este estudio fue evaluar la asociación entre los valores de proteína C reactiva (PCr) en plasma al ingreso sanatorial en adultos con COVID-19 y el requerimiento de asistencia respiratoria mecánica (ARM) durante la internación. Métodos: Cohorte retrospectiva, observacional, en un centro privado de la provincia de Buenos Aires. Se incluyeron a adultos internados con diagnóstico de COVID-19 por hisopado nasal, mediante real time transcription polymerasa chain reaction o antígeno. El desenlace primario fue la asociación entre valores altos de PCr en plasma al ingreso sanatorial (≥8 mg/L) y el requerimiento de ARM durante la internación. Resultados: De los 1.242 pacientes enrolados, 19,4% requirieron ARM y 11,7% fallecieron durante la internación. La PCr de los pacientes que requirieron ARM fue mayor que la de los que no la requirieron (9,45 [5,20-18,70] mg/L vs 4,95 [1,80-10,70] mg/L; p < 0,01). La PCr analizada como variable continua (OR = 1,39; IC95% 1,21-1,60; p < 0,001) y como variable categórica (≥8 mg/L) (OR = 2,66; IC95% 2,19-3,78; p < 0,001) presentó una asociación significativa con el requerimiento de ARM durante la internación. Secundariamente, se encontró una asociación significativa entre PCr y mortalidad intrahospitalaria. Conclusión: El valor de PCr en plasma al ingreso sanatorial podría predecir la evolución clínica en pacientes adultos internados por COVID-19. Resultados: De los 1.242 pacientes enrolados, 19,4% requirieron ARM y 11,7% fallecieron durante la internación. La PCr de los pacientes que requirieron ARM fue mayor que la de los que no la requirieron (9,45 [5,20-18,70] mg/L vs 4,95 [1,80-10,70] mg/L; p < 0,01). La PCr analizada como variable continua (OR = 1,39; IC95% 1,21-1,60; p < 0,001) y como variable categórica (≥8 mg/L) (OR = 2,66; IC95% 2,19-3,78; p < 0,001) presentó una asociación significativa con el requerimiento de ARM durante la internación. Secundariamente, se encontró una asociación significativa entre PCr y mortalidad intrahospitalaria. Conclusión: El valor de PCr en plasma al ingreso sanatorial podría predecir la evolución clínica en pacientes adultos internados por COVID-19.
Asunto(s)
Proteína C-Reactiva , COVID-19 , Adulto , Humanos , Hospitales , Estudios RetrospectivosRESUMEN
BACKGROUND: The relationship between antidepressant response and glial, inflammatory, and metabolic markers is poorly understood in depression. This study assessed the ability of biological markers to predict antidepressant response in major depressive disorder (MDD). METHODS: We included 31 MDD outpatients treated with escitalopram or sertraline for 8 consecutive weeks. The Montgomery-Åsberg Depression Rating Scale (MADRS) was administered at baseline and at week 4 and 8 of treatment. Concomitantly, blood samples were collected for the determination of serum S100B, C-reactive protein (CRP), and high-density lipoprotein cholesterol (HDL)-C levels. Treatment response was defined as ≥50% improvement in the MADRS score from baseline to either week 4 or 8. Variables associated with treatment response were included in a linear regression model as predictors of treatment response. RESULTS: Twenty-seven patients (87%) completed 8 weeks of treatment; 74% and 63% were responders at week 4 and 8, respectively. High S100B and low HDL-C levels at baseline were associated with better treatment response at both time points. Low CRP levels were correlated with better response at week 4. Multivariate analysis showed that high baseline S100B levels and low baseline HDL-C levels were good predictors of treatment response at week 4 (R2 = 0.457, P = .001), while S100B was at week 8 (R2 = 0.239, P = .011). Importantly, baseline S100B and HDL-C levels were not associated with depression severity and did not change over time with clinical improvement. CONCLUSIONS: Serum S100B levels appear to be a useful biomarker of antidepressant response in MDD even when considering inflammatory and metabolic markers.
Asunto(s)
Trastorno Depresivo Mayor , Antidepresivos/uso terapéutico , Biomarcadores , Proteína C-Reactiva/metabolismo , Depresión , Trastorno Depresivo Mayor/tratamiento farmacológico , Método Doble Ciego , Humanos , Pacientes Ambulatorios , Subunidad beta de la Proteína de Unión al Calcio S100 , Resultado del TratamientoRESUMEN
The relationship between inflammation and venous thrombosis is not well understood. An inflammatory response may be both the cause and consequence of venous thromboembolism (VTE). In fact, several risk factors of VTE modulate thrombosis through inflammatory markers. Acute pulmonary embolism (PE) is burdened by a remarkable mortality rate, up to 34% in severely ill patients presenting with hemodynamic instability. Initial mortality risk stratification is based on hemodynamic instability. Patients with a situation of hemodynamic stability require immediate further risk assessment based on clinical, imaging, and circulating biomarkers, as well as the presence of comorbidities. Some inflammatory biomarkers have shown potential usefulness in the risk stratification of patients with VTE, especially acute PE. C-reactive protein on admission is associated with 30-day mortality and bleeding in VTE patients. P-selectin is associated with right ventricle dysfunction in PE patients and might be associated with VTE recurrences and the extension of thrombosis. Tissue factor microparticles are associated with VTE recurrence in cancer-associated thrombosis. Other inflammatory biomarkers present scarce evidence (inflammatory cytokines, erythrocyte sedimentation rate, fibrinogen, leukocyte count). In this manuscript, we will review the prognostic role of different inflammatory biomarkers available both for clinical practice and research in VTE patients.
Asunto(s)
Mediadores de Inflamación/sangre , Embolia Pulmonar , Tromboembolia Venosa , Disfunción Ventricular Derecha , Biomarcadores/sangre , Sedimentación Sanguínea , Proteína C-Reactiva/metabolismo , Citocinas/sangre , Supervivencia sin Enfermedad , Femenino , Fibrinógeno/metabolismo , Humanos , Recuento de Leucocitos , Masculino , Selectina-P/sangre , Embolia Pulmonar/sangre , Embolia Pulmonar/mortalidad , Tasa de Supervivencia , Tromboembolia Venosa/sangre , Tromboembolia Venosa/mortalidad , Disfunción Ventricular Derecha/sangre , Disfunción Ventricular Derecha/mortalidadRESUMEN
La Proteína C reactiva es un biomarcador sensible, específico y buen predictor del fracaso terapéutico de las neumonías. A nivel mundial hay posturas controversiales sobre su utilidad. En nuestro medio no hay estudios reportados al respecto. El propósito de nuestro trabajo fue intentar predecir la evolución de la neumonía aguda comunitaria (NAC). A todos los pacientes con diagnostico de NAC ingresados al Hospital Español durante junio y julio de 2012 se les dosificó los niveles de PcR a las 24 y 72 hs. de iniciado el tratamiento. Se pudo correlacionar la buena evolución con la reducción de los niveles de PcR en un 25% (Δ PcR). También se observo que niveles elevados de PcR se correlacionan con la leucocitosis y el score CURB65. Se pudo concluir entonces que la PcR es un biomarcador de fácil acceso y buen predictor de la evolución de las NAC.
C-reactive protein is a biomarker sensitive, specific and good predictor of treatment failure in pneumonia. Worldwide there are controversial positions on their usefulness. In our country is not studies reported to respect. The purpose of our work was to try to predict the evolution of community acute pneumonia. All patients diagnosed with CAP admitted to Spanish Hospital during June and July 2012 were dosed RcP levels at 24 and 72 hours of starting treatment. We were able to correlate a good performance with reduced RcP levels by 25% (Δ RcP). We also observed that elevated RcP levels correlate with leukocytosis and CURB65 score. We conclude that RcP is a biomarker for easy access and good predictor of the development of the CAP.
RESUMEN
Se evaluó un método de aglutinación con látex para la detección de proteína C reactiva (PCR) (PCR-Látex, CENTIS) empleándose como referencia un test turbidimétrico (PCR-Turbilátex, Spinreact). Se procesaron en paralelo 97 sueros de pacientes con clínica sugestiva de inflamación y sepsis. El análisis estadístico incluyó la determinación de la sensibilidad, especificidad, valor predictivo positivo (VPP), valor predictivo negativo (VPN) y límites de detección. Los resultados obtenidos de sensibilidad: 97,8 %; especificidad: 98,0 %; VPP: 97,8 %; VPN: 98,0 %, con un límite de detección de 6 mg/L, pueden considerarse de satisfactorios, lo que permite contar con un procedimiento sencillo, rápido y eficiente que no requiere de un equipamiento especial.
Agglutination evaluation method related to use of latex for detection of reactive C protein (RCP) (RCP-Latex, CENTIS) was evaluated, using as reference a turbidimetry test (RCP-Turbilatex, Spinreact). In parallel, 97 sera from patients with possibilities of inflammation and sepsis were processed. Statistical analysis included determination of sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and detection limits. Results achieved for sensitivity: 97,8 %; specificity: 98,0 %; NVP: 97,8 %; NPV: 98 % with a detection limit of 6 mg/L, may be considered of satisfactory, allowing to have a simple, fast, and efficient procedure without a especial equipment.